Skip to main content
logo
Neuland Laboratories Limited (NSE:NEULANDLAB)
India flag India · Delayed Price · Currency is INR
16,598
-478 (-2.80%)
Nov 21, 2025, 3:30 PM IST

Neuland Laboratories Revenue

Neuland Laboratories had revenue of 5.14B INR in the quarter ending September 30, 2025, with 65.44% growth. This brings the company's revenue in the last twelve months to 15.33B, up 0.34% year-over-year. In the fiscal year ending March 31, 2025, Neuland Laboratories had annual revenue of 14.77B, down -5.24%.

Revenue (ttm)
15.33B
Revenue Growth
+0.34%
P/S Ratio
13.88
Revenue / Employee
8.55M
Employees
1,794
Market Cap
212.91B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202514.77B-817.43M-5.24%
Mar 31, 202415.59B3.67B30.81%
Mar 31, 202311.91B2.40B25.20%
Mar 31, 20229.52B147.07M1.57%
Mar 31, 20219.37B1.73B22.64%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries549.64B
Aurobindo Pharma325.14B
Cipla279.66B
Zydus Lifesciences244.94B
Apollo Hospitals Enterprise232.65B
Biocon164.76B
Alkem Laboratories138.90B
Mankind Pharma135.46B
Revenue Rankings

Neuland Laboratories News

More News